Mitigating Brain MR Imaging Degradation Due to Ferumoxytol Therapy in Patients with Iron Deficiency Anemia
American Journal of Neuroradiology · 2025
DOI: 10.3174/ajnr.a8772 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Neuroradiology, 2025. Verfasst von Seunghong Rhee und 2 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Radiology, Texas Tech University Health Sciences Center El Paso, El Paso, Texas. Hauptthemen laut MEDLINE: Ferrosoferric Oxide, Magnetic Resonance Imaging, Anemia, Iron-Deficiency, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Radiology, Texas Tech University Health Sciences Center El Paso, El Paso, Texas.
- From the Department of Radiology, Texas Tech University Health Sciences Center El Paso, El Paso, Texas Thomas.ONeill@ttuhsc.edu.
Zitieren
APA
Rhee, S., Tran, A. M., & O'Neill, T. J. (2025). Mitigating Brain MR Imaging Degradation Due to Ferumoxytol Therapy in Patients with Iron Deficiency Anemia. American Journal of Neuroradiology. https://doi.org/10.3174/ajnr.a8772
Vancouver
Rhee S, Tran AM, O'Neill TJ. Mitigating Brain MR Imaging Degradation Due to Ferumoxytol Therapy in Patients with Iron Deficiency Anemia. American Journal of Neuroradiology. 2025. doi:10.3174/ajnr.a8772
BibTeX
@article{Rhee2025,
author = {Rhee, Seunghong and Tran, An M and O'Neill, Thomas J},
title = {Mitigating Brain MR Imaging Degradation Due to Ferumoxytol Therapy in Patients with Iron Deficiency Anemia},
journal = {American Journal of Neuroradiology},
year = {2025},
doi = {10.3174/ajnr.a8772}
}
EUVIMED